Maitreya Medicare (NSE:MAITREYA) Current Deferred Revenue: ₹0.0 Mil (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAITREYA Maitreya Medicare Ltd NSE:MAITREYA
18 GF Score
Price ₹111.00
View Full Analysis

What is Maitreya Medicare Current Deferred Revenue?

Maitreya Medicare NSE:MAITREYA 18 Current Deferred Revenue is ₹0.0 Mil as of Sep. 2023. GuruFocus rates NSE:MAITREYA with a GF Score™ of 18/100.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Maitreya Medicare's current deferred revenue for the quarter that ended in Sep. 2023 was ₹0.0 Mil.

Maitreya Medicare Current Deferred Revenue Related Terms

Maitreya Medicare Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Maitreya Medicare's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare Current Deferred Revenue Chart

Maitreya Medicare Annual Data
Trend Mar21 Mar22 Mar23
Current Deferred Revenue
0.00 0.00 0.00

Maitreya Medicare Semi-Annual Data
Mar21 Mar22 Mar23 Sep23
Current Deferred Revenue 0.00 0.00 0.00 0.00
NSE:MAITREYA
18GF Score
Maitreya Medicare Ltd NSE:MAITREYA
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of ₹0.0 Mil mean?
Maitreya Medicare (NSE:MAITREYA) has a Current Deferred Revenue of ₹0.0 Mil as of Sep. 2023. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Maitreya Medicare and its competitors.
Is Maitreya Medicare's Current Deferred Revenue too high?
Maitreya Medicare's current Current Deferred Revenue is ₹0.0 Mil. Overall, Maitreya Medicare has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's Current Deferred Revenue compare to HCA and DVA?
Maitreya Medicare's Current Deferred Revenue of ₹0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Maitreya Medicare and its competitors. Maitreya Medicare's current Current Deferred Revenue is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Maitreya Medicare (NSE:MAITREYA) has a current Current Deferred Revenue of ₹0.0 Mil. The current Current Deferred Revenue is ₹0.0 Mil. Maitreya Medicare's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current Current Deferred Revenue is ₹0.0 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maitreya Medicare Business Description

Address Nr. Someshwara Char Rasta, Udhana - Magdalla Road, Surat, GJ, IND, 395007
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
18GF Score

Get the complete analysis for NSE:MAITREYA

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹111.00
Price